Disclosure Panels Details Page
Kidney Cancer Panel - Disclosures as of 04/03/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Neeraj Agarwal MD | None | AstraZeneca Pharmaceuticals LP Eisai Inc. Eli Lilly and Company Exelixis Inc. Foundation Medicine Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Ajjai Alva MBBS | AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol-Myers Squibb Company Clovis Oncology Eisai Inc. esanik Genentech, Inc. ionis Janssen Pharmaceutica Products, LP Merck & Co., Inc. Progenics Prometheus |
None | None | None | - |
| Kathryn Beckermann MD, PhD | Bristol-Myers Squibb Company | Aravive | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Shawna Boyle MD | None | None | None | None | ✔ |
| Maria Carlo MD | None | None | None | None | ✔ |
| Toni Choueiri MD | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Eisai Inc. Eli Lilly and Company EMD Serono Exelixis Inc. Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. |
Bristol-Myers Squibb Company Eli Lilly and Company Merck & Co., Inc. Pfizer Inc. |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Exelixis Inc. Merck & Co., Inc. Pfizer Inc. |
None | ✔ |
| Brian Costello MD, MS | National Cancer Institute Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | None | ✔ |
| Ithaar Derweesh MD | Pfizer Inc. | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Tanya Fischer MEd, MLIS | None | None | None | None | - |
| Saby George MD, FACP | None | None | Bayer HealthCare Bristol-Myers Squibb Company EMD Serono Exelixis Inc. sanofi-aventis U.S. |
None | ✔ |
| John Gore MD, MS | Ferring Pharmaceuticals | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Lisa Gurski PhD | None | None | None | None | - |
| Naomi Haas MD | Roche Laboratories, Inc. | Exelixis Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. |
None | None | ✔ |
| Lydia Hammond MBA | None | None | None | Merck & Co., Inc.|NeoGenomics Laboratories | ✔ |
| Steven Hancock MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Eric Jonasch MD | None | Eisai Inc. Exelixis Inc. Genentech, Inc. Ipsen Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Roche Laboratories, Inc. |
None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Rashmi Kumar PhD | None | None | None | None | - |
| Christos Kyriakopoulos MD | None | None | None | None | ✔ |
| Elaine Lam MD | Calithera Biosciences | None | None | None | ✔ |
| Clayton Lau MD | None | None | None | None | ✔ |
| Bryan Lewis JD | None | Bristol-Myers Squibb Company | None | None | ✔ |
| Brandon Manley MD | None | None | None | None | ✔ |
| Brittany McCreery MD, MBA | None | None | None | None | - |
| M. Dror Michaelson MD, PhD | None | Eisai Inc. Exelixis Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Amir Mortazavi MD | Acerta Pharma Astellas Pharma US, Inc. Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Mirati Therapeutics; MethylGene, Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. Seattle Genetics, Inc. |
None | Debiopharm Group Seattle Genetics, Inc. |
None | ✔ |
| Angela Motter PhD | None | None | None | None | ✔ |
| Robert Motzer MD | Bristol-Myers Squibb Company Eisai Inc. Exelixis Inc. Genentech, Inc. Pfizer Inc. |
Eli Lilly and Company Genentech, Inc. Merck & Co., Inc. Pfizer Inc. |
None | None | ✔ |
| Lakshminarayanan Nandagopal MD | None | None | None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Phillip Pierorazio MD | OLYMPUS Trial | Ethicon, Inc. Urogen Pharmaceutical |
None | None | ✔ |
| Elizabeth Plimack MD, MS | Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Genentech, Inc. Infinity Pharmaceuticals, Inc Merck & Co., Inc. Peloton Therapeutics, Inc. Pfizer Inc. |
Bristol-Myers Squibb Company Flatiron Health, Inc. Genentech, Inc. Merck & Co., Inc. Seattle Genetics, Inc. |
None | None | ✔ |
| Lee Ponsky MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Sundhar Ramalingam MD | Exelixis Inc. | None | Bayer HealthCare | None | ✔ |
| Leslie Ray PharmD | None | None | None | None | ✔ |
| Zachary Smith MD | None | None | None | None | - |
| Bradley Somer MD | None | None | None | None | ✔ |
| Jeffrey Sosman MD | None | Array Bristol-Myers Squibb Company Curis Genentech, Inc. Nektar Therapeutics |
None | None | ✔ |
| Bettyanne Sunderland BSN, RN, OCN | None | None | None | None | ✔ |
| Erin Vidic | None | None | None | None | - |